New York Times refuses to back down after more ‘Enemies of the People’ rhetoric from Trump

President Trump attacked The New York Times on Truth Social as “seditious, perhaps even treasonous” and called the paper and other outlets “true Enemies of the People” after the Times published recent pieces suggesting he has shown signs of fatigue and reduced public engagement; Trump defended his vigor, cited lengthy medical exams and cognitive tests he said he “ACED,” and insisted reporters are wrong. The Times pushed back, saying its reporting on the president’s health is heavily sourced from people close to him and medical experts and that it “won’t be deterred by false and inflammatory language” that distorts the role of a free press, noting the long-standing sensitivity around presidential health. The spat adds to broader tensions between Trump and major media — including his $15 billion defamation suit against the Times and other legal actions against AP and CBS — underscoring sustained friction with potential implications for press freedom and political discourse.

Analysis

President Donald Trump publicly attacked The New York Times on Truth Social, calling recent reports on his health “seditious, perhaps even treasonous” and labeling the paper and other outlets “true Enemies of the People,” after the Times published articles on Nov. 25 and Dec. 2 suggesting signs of fatigue and reduced public engagement and a Dec. 8 opinion linking vigor to approval ratings. Trump defended his fitness, citing lengthy medical examinations and three cognitive tests he said he “ACED,” and framed the reporting as false.

The Times responded through spokeswoman Nicole Taylor, saying its reporting is “heavily sourced” to people close to the president and medical experts and that it will not be deterred by inflammatory language; the exchange occurs against a broader litigation backdrop in which Trump has a $15 billion defamation suit against the Times (filed in September) and has pursued other legal cases involving major outlets. Per-signal outputs show negative per-ticker sentiment for NYT (-0.4) but a low overall market-impact score (0.05), indicating reputational and legal risk without immediate systemic market disruption.

For investors, the situation increases headline-driven volatility and creates a legal overhang that could lead to further costs or distraction for management; monitor legal filings and corporate disclosures for any quantifiable financial impact before adjusting position sizing.

Key Decisions for Investors

• Monitor developments in the $15 billion defamation suit and any new legal filings closely and consider hedging or trimming NYT exposure until the potential liability and reserve impact are clearer
• Avoid initiating new long positions on NYT ahead of material legal or editorial developments given negative per-ticker sentiment (-0.4) and heightened headline risk
• Watch for company disclosures or management commentary on litigation risk and financial reserves and reassess positions only if reporting demonstrates a material earnings or cash-flow impact